Intellectual Property

Our Leading IP Position

Expanding our intellectual property portfolio is essential in order to successfully implement our strategy and reach our ambition to become a leading biotech in the microbiome industry.

By filing our own IP in the US and Europe, and by licensing in available patents from world class academic, we are building a leadership IP position in the Christensenella space.

YSOPIA Bioscience filed proprietary patent families protecting christensenella modulation for therapeutic use.

In September 2018, we acquired an exclusive licence for the Christensenella patents from Cornell University (Ithaca, NY, USA) covering the applications of Christensenella as a treatment for obesity and metabolic diseases. We’ve also had a number of patents granted by the USPTO.

In April 2020, YSOPIA Bioscience entered into an exclusive license agreement with Spanish National Research Council (CSIC), for its patent application dedicated to the therapeutic use of Christensenella gut bacteria in mood disorders
Read our press release

 

We are actively scouting at the international level for patent licensing opportunities in order to continue expanding our intellectual property portfolio.

> Discover our pipeline

Microbiome & us
News
May 4, 2021
We are looking for a Senior Scientist in Microbiology & Biotechnology – Team Leader position | WHAT WE...
> more
Mar 29, 2021
Lancement de l’Alliance Promotion Microbiote | L’Alliance Promotion Microbiote est lancée : fruit de l’union...
> more
Press / Media
Mar 4, 2021
Read the full article    
> more
Mar 4, 2021
15h Biotech Express Jeudi : Abivax, Ysopia Bioscience, HealthTech Innovation Days, Conférence White Fund Par Rédaction...
> more
Publications
Apr 22, 2020
Keystone gut bacteria are the foundation of the whole microbial ecosystem because they provide very specific metabolic...
> more
Dec 6, 2019
The term “microbiome” refers to the collection of microorganisms (or microbiota) – including bacteria, viruses and...
> more
now on twitter
YSOPIA Bioscience

This #study highlights how the #microbiome changes with HCC development and identify potential therapeutic targets… t.co/quI7CM5XML

YSOPIA Bioscience © 2021 - all rights reserved terms and conditions